Vitamin D and its receptor during late development

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 2, 2015, Pages 171-180

  Goltzman, D ^a   Hendy, G N ^a   White, J H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

1,25(OH)2< inf>D VDR system; C MYC; Calcium; FGF23; PTH; Vitamin D

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PROTEIN MAD1; WNT PROTEIN; 1,25-DIHYDROXYVITAMIN D; VITAMIN D;

BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; CALCIUM ABSORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; FETUS DEVELOPMENT; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; LACTATION; ONTOGENY; OSSIFICATION; OSTEOLYSIS; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW; TRANSCYTOSIS; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; ANIMAL; BONE DEVELOPMENT; DRUG EFFECTS; EPIDERMIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

ANIMALS; EPIDERMIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH AND DEVELOPMENT; HUMANS; IMMUNE SYSTEM; OSTEOGENESIS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGICAL PHENOMENA; VITAMIN D;

EID: 84921064755     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.05.026     Document Type: Review

References (130)

1. MacLaughlin J.A., Anderson R.R., Holick M.F. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 1982, 216:1001-1003.
2. Zhu J.G., Ochalek J.T., Kaufmann M., Jones G., Deluca H.F. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15650-15655.
3. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
4. Brenza H.L., DeLuca H.F. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch. Biochem. Biophys. 2000, 381:143-152.
5. Murayama A., Takeyama K., Kitanaka S., Kodera Y., Kawaguchi Y., Hosoya T., Kato S. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999, 140:2224-2231.
6. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., Fujita T., Nakahara K., Fukumoto S., Yamashita T. FGF 23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 2004, 19:429-435.
7. Liu P., Stenger S., Li H., Wenzel L., Tan B., Krutzik S., Ochoa M., Schauber J., Wu K., Meinken C. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
8. White J.H. Vitamin D, metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 2012, 13:21-29.
9. St-Arnaud R. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J. Steroid Biochem. Mol. Biol. 2010, 121:254-256.
10. Bai X.Y., Miao D., Goltzman D., Karaplis A.C. The autosomal dominant hypophosphatemic rickets R178Q mutationin fibroblat growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J. Biol. Chem. 2003, 278:9843-9849.
11. Pike J.W., Meyer M.B. Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid Biochem. Mol. Biol. Nov 12 2013, (pii: S0960-0760(13)00234-3, Epub ahead of print, PMID: 24239506). 10.1016/j.jsbmb.2013.11.004.
12. Haussler M.R., Whitfield G.K., Kaneko I., Haussler C.A., Hsieh D., Hsieh J.C., Jurutka P.W. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 2013, 92:77-98.
13. Dimitrov V., Salehi-Tabar R., An B.-S., White J.H. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor. J. Steroid Biochem. Mol. Biol. Jul 30 2013, (pii: S0960-0760(13)00141-6, Epub ahead of print, PMID: 23911725). 10.1016/j.jsbmb.2013.07.012.
14. Heikkinen S., Väisänen S., Pehkonen P., Seuter S., Benes V., Carlberg C. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011, 39:9181-9193.
15. Meyer M.B., Goetsch P.D., Pike J.W. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 2010, 121:136-141.
16. Meyer M.B., Goetsch P.D., Pike J.W. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 2012, 26:37-51.
17. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., Handunnetthi L., Handel A.E., Disanto G., Orton S.M., Watson C.T., Morahan J.M., Giovannoni G., Ponting C.P., Ebers G.C., Knight J.C. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010, 20:1352-1360.
18. Dhawan P., Peng X., Sutton A.L.M., MacDonald P.N., Croniger C.M., Trautwein C., Centrella M., McCarthy T.L., Christakos S. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol. Cell. Biol. 2005, 25:472-487.
19. Martowicz M.L., Meyer M.B., Pike J.W. The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers. J. Cell. Biochem. 2011, 112:2030-2045.
20. Zella L.A., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24:128-147.
21. Keith M.E., LaPorta E., Welsh J. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling. Mol. Carcinog. 2014, 53(4):286-299.
22. Murayama A., Kim M.-s., Yanagisawa J., Takeyama K.-i., Kato S. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2004, 23:1598-1608.
23. Yang L.L., Peng R.Y. Unveiling hair follicle stem cells. Stem Cell Rev. 2010, 6(4):658-664.
24. An B.-S., Tavera-Mendoza L.E., Dimitrov V., Wang X., Calderon M., Wang H.-J., White J.H. Stimulation of SIRT1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol. 2010, 30:4890-4900.
25. Lu X., Farmer P., Rubin J., Nanes M.S. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J. Cell. Biochem. 2004, 92:833-848.
26. Szeto F.L., Sun J., Kong J., Duan Y., Liao A., Madara J.L., Li Y.C. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J. Steroid Biochem. Mol. Biol. 2007, 103:563-566.
27. Sun J., Kong J., Duan Y., Szeto F.L., Liao A., Madara J.L., Li Y.C. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E315-E322.
28. Fretz J.A., Zella L.A., Kim S., Shevde N.K., Pike J.W. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol. Endocrinol. 2006, 20:2215-2230.
29. Larriba M.J., Valle N., Palmer H.G., Ordonez-Moran P., Alvarez-Diaz S., Becker K.F., Gamallo C., de Herreros A.G., González-Sancho J.M., Muñoz A. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr. Relat. Cancer 2007, 14:141-151.
30. Saunders L.R., McClay D.R. Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition. Development 2014, 141(7):1503-1513.
31. De Craene B., Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 2013, 13:97-110.
32. Barrallo-Gimeno A., Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161.
33. Pálmer H.G., Larriba M.J., García J.M., Ordóñez-Morán P., Peña C., Peiró S., Puig I., Rodríguez R., de la Fuente R., Bernad A., Pollán M., Bonilla F., Gamallo C., de Herreros A.G., Muñoz A. The transcription factor SNAIL represses Vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med. 2004, 10:917-919.
34. Peña C., García J.M., Silva J., García V., Rodríguez R., Alonso I., Millán I., Salas C., de Herreros A.G., Muñoz A., Bonilla F. E-cadherin and Vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet. 2005, 14:3361-3370.
35. de Frutos C.A., Dacquin R., Vega S., Jurdic P., Machuca-Gayet I., Nieto M.A. Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J. 2009, 28(6):686-696.
36. Fraser D., Kooh S.W., Kind H.P., Holick M.F., Tanaka Y., DeLuca H.F. Pathogenesis of hereditary vitamin-D-dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N. Engl. J. Med. 1973, 289:817-822.
37. Kitanaka S., Takeyama K., Murayama A., Sato T., Okumura K., Nogami M., Hasegawa Y., Niimi H., Yanagisawa J., Tanaka T., Kato S. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 1998, 338:653-661.
38. Malloy P.J., Hochberg Z., Tiosano D., Pike J.W., Hughes M.R., Feldman D. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J. Clin. Invest. 1990, 86:2071-2079.
39. Malloy P.J., Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol. Metab. Clin. N. Am. 2010, 39:333-346.
40. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7498-7503.
41. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
42. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9831-9835.
43. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., Stockmans I., Van Herck E., Kato S., Bindels R.J., Collen D., Carmeliet P., Bouillon R., Carmeliet G. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13324-13329.
44. Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., Möller G., Adamski J., Balling R. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 2002, 16:1524-1537.
45. Goltzman D. Vitamin D, action: lessons learned from genetic mouse models. Ann. N. Y. Acad. Sci. 2010, 1192:145-152.
46. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 2002, 110:229-238.
47. Zhou C., Lu F., Cao K., Xu D., Goltzman D., Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008, 74(2):70-79.
48. Zhu Y., Zhou R., Yang R., Zhang Z., Bai Y., Chang F., Li L., Sokabe M., Goltzman D., Miao D., Chen L. Abnormal neurogenesis in the dentate gyrus of adult mice lacking 1,25-dihydroxy vitamin D3 (1,25-(OH)2 D3). Hippocampus 2012, 22(3):421-433.
49. Shore R.M., Chesney R.W. Rickets: part I. Pediatr. Radiol. 2013, 43:140-151.
50. Shore R.M., Chesney R.W. Rickets: part II. Pediatr. Radiol. 2013, 43:152-172.
51. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., Goltzman D. Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J. Biol. Chem. 2004, 279:16754-16766.
52. Kovacs C.S. Maternal vitamin D deficiency: fetal and neonatal implications. Semin. Fetal Neonatal Med. 2003, 18:129-135.
53. Fenton E., Britton H.G. 25-hydroxycholecalciferol 1 alpha-hydroxylase activity in the kidney of the fetal, neonatal and adult guinea pig. Biol. Neonate 1980, 37:254-256.
54. Gray T.K., Lowe W., Lester G.E. Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. Endocr. Rev. 1981, 2:264-274.
55. Turner M., Barre P.E., Benjamin A., Goltzman D., Gascon-Barre M. Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy?. Miner. Electrolyte Metab. 1988, 14:246-252.
56. Kirby B.J., Karaplis A.C., Kovacs C.S. Calcitriol increases during pregnancy and bone formation upregulates post-lactation without parathyroid hormone. Bone 2011, 48:S101-S102.
57. Ross R., Care A.D., Robinson J.S., Pickard D.W., Weatherley A.J. Perinatal 1,25-dihydroxycholecalciferol in the sheep and its role in the maintenance of the transplacental calcium gradient. J. Endocrinol. 1980, 87:17-18.
58. Brommage R., Baxter D.C., Gierke L.W. Vitamin D-independent intestinal calcium and phosphorus absorption during reproduction. Am. J. Physiol. 1990, 259:G631-G638.
59. Fudge N.J., Kovacs C.S. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology 2010, 151:886-895.
60. Halloran B.P., DeLuca H.F. Skeletal changes during pregnancy and lactation: the role of vitamin D. Endocrinology 1980, 107:1923-1929.
61. Lachenmaier-Currle U., Breves G., Harmeyer J. Role of 1,25-(OH)2D3 during pregnancy: studies with pigs suffering from pseudo-vitamin D-deficiency rickets, type I. Q. J. Exp. Physiol. 1989, 74:875-881.
62. Kovacs C.S., Woodland M.L., Fudge N.J., Friel J.K. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E133-E144.
63. Miller S.C., Halloran B.P., DeLuca H.F., Jee W.S. Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif. Tissue Int. 1983, 35:455-460.
64. Lachenmaier-Currle U., Harmeyer J. Placental transport of calcium and phosphorus in pigs. J. Perinat. Med. 1989, 17:127-136.
65. Young B.E., Cooper E.M., McIntyre A.W., Kent T., Witter F., Harris Z.L., O'Brien K.O. Placental vitamin D receptor (VDR) expression is related to neonatal vitamin D status, placental calcium transfer, and fetal bone length in pregnant adolescents. FASEB J. 2014, 28(5):2029-2037.
66. Ji J., Lu R., Zhou X., Xue Y., Shi C., Goltzman D., Miao D. 1,25-Dihydroxyvitamin D[U+2083] contributes to regulating mammary calcium transport and modulates neonatal skeletal growth and turnover cooperatively with calcium. Am. J. Physiol. Endocrinol. Metab. 2011, 301(5):E889-E900.
67. Halloran B.P. Cellular growth and differentiation during embryogenesis and fetal development. The role of vitamin D,. Adv. Exp. Med. Biol. 1994, (352):227-236.
68. Ardeshirpour L., Dann P., Adams D.J., Nelson T., VanHouten J., Horowitz M.C., Wysolmerski J.J. Weaning triggers a decrease in receptor activator of nuclear factor-kappaB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice. Endocrinology 2007, 148(8):3875-3886.
69. Bowman B.M., Miller S.C. Skeletal adaptations during mammalian reproduction. J. Musculoskelet. Neuronal Interact. 2001, 1(4):347-355.
70. Kirby B.J., Ma Y., Martin H.M., Buckle Favaro K.L., Karaplis A.C., Kovacs C.S. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. J. Bone Miner. Res. 2013, 28(9):1987-2000.
71. Balsan S., Garabedian M., Larchet M., Gorski A.M., Cournot G., Tau C., Bourdeau A., Silve C., Ricour C. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 1986, 77:1661-1667.
72. Hochberg Z., Tiosano D., Even L. Calcium therapy for calcitriol-resistant rickets. J. Pediatr. 1992, 121:803-808.
73. Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H., St Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1 α -hydroxylase (CYP27B1). Bone 2003, 32:332-340.
74. Amling M., Priemel M., Holzmann T., Chapin K., Rueger J.M., Baron R., Demay M.B. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140(11):4982-4987.
75. Meyer M.B., Watanuki M., Kim S., Shevde N.K., Pike J.W. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 2006, 20:1447-1461.
76. Fleet J.C., Wood R.J. Identification of calbindin D-9k mRNA and its regulation by 1,25-dihydroxyvitamin D3 in Caco-2 cells. Arch. Biochem. Biophys. 1994, 308(1):171-174.
77. Christakos S., Dhawan P., Ajibade D., Benn B.S., Feng J., Joshi S.S. Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D. J. Steroid Biochem. Mol. Biol. 2010, 121(1-2):183-187.
78. Hoenderop J.G., Dardenne O., Van Abel M., van der Kemp A.W., Van Os C.H., Arnaud R., Bindels R.J. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1 α -hydroxylase knockout mice. FASEB J. 2002, 16:1398-1406.
79. Kutuzova G.D., Sundersingh F., Vaughan J., Tadi B.P., Ansay S.E., Christakos S., Deluca H.F. TRPV6 is not required for 1alpha,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19655-19659.
80. Forster R.E., Jurutka P.W., Hsieh J.C., Haussler C.A., Lowmiller C.L., Kaneko I., Haussler M.R., Kerr Whitfield G. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem. Biophys. Res. Commun. 2011, 414:557-562.
81. Taketani Y., Segawa H., Chikamori M., Morita K., Tanaka K., Kido S., Yamamoto H., Iemori Y., Tatsumi S., Tsugawa N., Okano T., Kobayashi T., Miyamoto K., Takeda E. Regulation of type II renal Na+ -dependent inorganic phosphate transporters by 1,25-dihydroxyvitamin D3. Identification of a vitamin D-responsive element in the human NAPi-3 gene. J. Biol. Chem. 1998, 273:14575-14581.
82. Russell J., Silver J., Sherwood L.M. The effects of calcium and Vitamin D metabolites on cytoplasmic mRNA coding for pre-proparathyroid hormone in isolated parathyroid cells. Trans. Assoc. Am. Phys. 1984, 97:296-303.
83. DeMay M.B., Kiernan M.S., DeLuca H.F., Kronenberg H.M. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:8097-8101.
84. Kremer R., Bolivar I., Goltzman D., Hendy G.N. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989, 125:935-941.
85. Kolek O.I., Hines E.R., Jones M.D., Lesueur L.K., Lipko M.A., Kiela P.R., Collins J.F., Haussler M.R., Ghishan F.K. 1a25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G1036-G1042.
86. Lin R., Amizuka N., Sasaki T., Aarts M.M., Ozawa H., Goltzman D., Henderson J.E., White J.H. 1Alpha,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J. Bone Miner. Res. 2002, 17(9):604-612.
87. Tanaka H., Seino Y. Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition. J. Steroid Biochem. Mol. Biol. 2004, 89-90:343-345.
88. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 1992, 3:66-80.
89. Gibbs C.J., Peacock M. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad. Med. J. 1986, 6:937-938.
90. Skalova S., Cerna L., Bayer M., Kutilek S., Konrad M., Schlingmann K.P. Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia. Iran J. Kidney Dis. 2013, 7(2):160-164.
91. Kim S., Yamazaki M., Zella L.A., Shevde N.K., Pike J.W. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 2006, 26:6469-6486.
92. Lanske B., Densmore M.J., Erben R.G. Vitamin D endocrine system and osteocytes. Bonekey Rep. 2014, 3:494.
93. Drissi H., Pouliot A., Koolloos C., Stein J., Lian J., Stein G., van Wijnen A. 1,25-Dihydroxyvitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp. Cell Res. 2002, 274:323-333.
94. Lieben L., Masuyama R., Torrekens S., Van Looveren R., Schrooten J., Baatsen P., Lafage-Proust M.H., Dresselaers T., Feng J.Q., Bonewald L.F., Meyer M.B., Pike J.W., Bouillon R., Carmeliet G. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 2012, 122:1803-1815.
95. Gardiner E.M., Baldock P.A., Thomas G.P., Sims N.A., Henderson N.K., Hollis B., White C.P., Sunn K.L., Morrison N.A., Walsh W.R., Eisman J.A. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J. 2000, 14:1908-1916.
96. Xue Y., Karaplis A.C., Hendy G.N., Goltzman D., Miao D. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum. Mol. Genet. 2005, 14(11):1515-1528.
97. Xue Y., Karaplis A.C., Hendy G.N., Goltzman D., Miao D. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology 2006, 147(10):4801-4810.
98. Goltzman D. Use of genetically modified mice to examine the skeletal anabolic activity of vitamin D. J. Steroid Biochem. Mol. Biol. 2007, 103(3-5):587-591.
99. Samadfam R., Xia Q., Miao D., Hendy G.N., Goltzman D. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone. J. Bone Miner. Res. 2008, 23(8):1257-1266.
100. Lam N.N., Triliana R., Sawyer R.K., Atkins G.J., Morris H.A., O'Loughlin P.D., Anderson P.H. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. J. Steroid Biochem. Mol. Biol. 2014, http://dx.doi.org/10.1016/j.jsbmb.2014.01.002 (in press).
101. Terpening C.M., Haussler C.A., Jurutka P.W., Galligan M.A., Komm B.S., Haussler M.R. The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation. Mol. Endocrinol. 1991, 5:373-385.
102. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., Ducy P., Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
103. Oury F., Ferron M., Huizhen W., Confavreux C., Xu L., Lacombe J., Srinivas P., Chamouni A., Lugani F., Lejeune H., Kumar T.R., Plotton I., Karsenty G. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J. Clin. Invest. 2013, 123:2421-2433.
104. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. b-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001, 105:533-545.
105. Cianferotti L., Cox M., Skorija K., Demay M.B. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9428-9433.
106. Salehi-Tabar R., Nguyen-Yamamoto L., Tavera-Mendoza L.E., Quail T., Dimitrov V., An B.S., Glass L., Goltzman D., White J.H. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(46):18827-18832.
107. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
108. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
109. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E., Dionne S., Servant M.J., Bitton A., Seidman E.G., Mader S., Behr M.A., White J.H. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn's disease. J. Biol. Chem. 2010, 285:2227-2231.
110. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
111. Adorini L., Penna G., Giarratana N., Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 2003, 88:227-233.
112. Yip K.H., Kolesnikoff N., Yu C., Hauschild N., Taing H., Biggs L., Goltzman D., Gregory P.A., Anderson P.H., Samuel M.S., Galli S.J., Lopez A.F., Grimbaldeston M.A. Mechanisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation. J. Allergy Clin. Immunol. 2014, 133:1356-1364.
113. Mahon B.D., Wittke A., Weaver V., Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 2003, 89:922-932.
114. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179:1634-1647.
115. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 2008, 8:685-698.
116. Palmer M.T., Lee Y.K., Maynard C.L., Oliver J.R., Bikle D.D., Jetten A.M., Weaver C.T. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J. Biol. Chem. 2011, 286:997-1004.
117. Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F.J., Garra A.O. 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+T cells to enhance the development of Th2 cells. J. Immunol. 2001, 167:4974-4980.
118. Joshi S., Pantalena L.C., Liu X.K., Gaffen S.L., Liu H., Rohowsky-Kochan C., Ichiyama K., Yoshimura A., Steinman L., Christakos S., Youssef S. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 2011, 31:3653-3669.
119. Kotake S., Yago T., Kawamoto M., Nanke Y. Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial human osteoclastology. J. Bone Miner. Metab. 2012, 30(2):125-135.
120. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-malefyt R., Coffman R.L., Hawrylowicz C.M., Garra A.O. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195:603-616.
121. Adams J.S., Liu P.T., Chun R., Modlin R.L., Hewison M. Vitamin D in defense of the human immune response. Ann. N. Y. Acad. Sci. 2007, 1117:94-105.
122. Grishkan I.V., Fairchild A.N., Calabresi P.A., Gocke A.R. 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(52):21101-21106.
123. Augustine M.V., Leonard M.B., Thayu M., Baldassano R.N., de Boer I.H., Shults J., Denson L.A., Deboer M.D., Herskovitz R., Denburg M.R. Changes in vitamin D-related mineral metabolism following induction with anti-tumor necrosis factor-α therapy in Crohn's disease. J. Clin. Endocrinol. Metab. 2014, (99):E991-E998.
124. Wahono C.S., Rusmini H., Soelistyoningsih D., Hakim R., Handono K., Endharti A.T., Kalim H., Widjajanto E. Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int. J. Clin. Exp. Med. 2014, 7(1):22-31.
125. Mosaad Y.M., Hammad E.M., Fawzy Z., Abdal Aal I.A., Youssef H.M., Elsaid T.O., Monir R., El-Deek B.S. Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum. Immunol. 2014, 75(5):452-461.
126. Giulietti A., Gysemans C., Stoffels K., van Etten E., Decallonne B., Overbergh L., Bouillon R., Mathieu C. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 2004, 47:451-462.
127. Gysemans C., van Etten E., Overbergh L., Giulietti A., Eelen G., Waer M., Verstuyf A., Bouillon R., Mathieu C. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008, 57:269-275.
128. Nguyen M., d'Alesio A., Nguyen J.M., Pascussi M., Kumar R., Griffin M.D., Dong X., Guillozo H., Rizk-Rabin M., Rizk-Rabin C., Sinding M., Bougneres P., Jehan F., Garabedian M. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 2006, 21:886-894.
129. Tiosano D., Wildbaum G., Gepstein V., Verbitsky O., Weisman Y., Karin N., Eztioni A. The role of vitamin D receptor in innate and adaptive immunity: a study in hereditary vitamin D-resistant rickets patients. J. Clin. Endocrinol. Metab. 2013, 98(4):1685-1693.
130. Liu N.Q., Kaplan A.T., Lagishetty V., Ouyang Y.B., Ouyang Y., Simmons C.F., Equils O., Hewison M. Vitamin D and the regulation of placental inflammation. J. Immunol. 2011, 186:5968-5974.